Products for Research Use Only
RegisterLogin

PBI-1393

CAT: 0804-HY-123568Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-123568Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PBI-1393 (BCH-1393) is an anticancer agent that enhances Th1 type cytokine production and primary T cell activation[1].
CAS Number
175072-12-5
Product Name Alternative
BCH-1393
UNSPSC
12352005
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pbi-1393.html
Smiles
N=C(NCCC[C@@H](NC(OCCCCCN1C=NC2=C(N=CN=C12)N(C)C)=O)C(O)=O)N
Molecular Formula
C19H31N9O4
Molecular Weight
449.51
References & Citations
[1]Mustapha Allam, et al. Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clin Immunol. 2007 Dec;125 (3) :318-27.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-129693PBI 51
HY-150723PBI-6DNJ
HY-111029ALX-1393
HY-111029A-01ALX-1393 (TFA)
HY-101451-01PBIT
HY-106902-01F-1394
HY-124112PAM 1392
HY-130753JM 1397
HY-135224-011,4-PBIT (dihydrobromide)
HY-120865-011,3-PBIT (dihydrobromide)

Alternative Products

CatalogName
T33891-01PBI-1393
T14198-01ALX-1393
165838PBI 51
525972PBI-51
GTR19220816-01PBI-6DNJ
M10026-01PBI-4050
A19557-50ALX-1393 50mg
A19557-25ALX-1393 25mg
PVTY00526PBI Tet
A19557-5ALX-1393 5mg

Popular Products